20 April 2017 - Deborah Wilkes
Archived
Johnson & Johnson reported a 2.4% increase in its US OTC sales during the first quarter of 2017, thanks to the "strength" of its Tylenol analgesics.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.